Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 Sep-Oct;5(5):681–687. doi: 10.3201/eid0505.990509

Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication.

K Galil 1, L A Miller 1, M A Yakrus 1, R J Wallace Jr 1, D G Mosley 1, B England 1, G Huitt 1, M M McNeil 1, B A Perkins 1
PMCID: PMC2627730  PMID: 10511524

Abstract

An unlicensed injectable medicine sold as adrenal cortex extract (ACE*) and distributed in the alternative medicine community led to the largest outbreak of Mycobacterium abscessus infections reported in the United States. Records from the implicated distributor from January 1, 1995, to August 18, 1996, were used to identify purchasers; purchasers and public health alerts were used to identify patients. Purchasers and patients were interviewed, and available medical records were reviewed. Vials of ACE* were tested for mycobacterial contamination, and the product was recalled by the U.S. Food and Drug Administration. ACE* had been distributed to 148 purchasers in 30 states; 87 persons with postinjection abscesses attributable to the product were identified. Patient and vial cultures contained M. abscessus identical by enzymatic and molecular typing methods. Unusual infectious agents and alternative health practices should be considered in the diagnosis of infections that do not respond to routine treatment.

Full Text

The Full Text of this article is available as a PDF (199.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolan G., Reingold A. L., Carson L. A., Silcox V. A., Woodley C. L., Hayes P. S., Hightower A. W., McFarland L., Brown J. W., 3rd, Petersen N. J. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis. 1985 Nov;152(5):1013–1019. doi: 10.1093/infdis/152.5.1013. [DOI] [PubMed] [Google Scholar]
  2. Butler W. R., Jost K. C., Jr, Kilburn J. O. Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol. 1991 Nov;29(11):2468–2472. doi: 10.1128/jcm.29.11.2468-2472.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Driscoll M. S., Tyring S. K. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):495–496. doi: 10.1016/s0190-9622(97)80242-3. [DOI] [PubMed] [Google Scholar]
  4. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., Kessler R. C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998 Nov 11;280(18):1569–1575. doi: 10.1001/jama.280.18.1569. [DOI] [PubMed] [Google Scholar]
  5. Kuritsky J. N., Bullen M. G., Broome C. V., Silcox V. A., Good R. C., Wallace R. J., Jr Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med. 1983 Jun;98(6):938–939. doi: 10.7326/0003-4819-98-6-938. [DOI] [PubMed] [Google Scholar]
  6. Lowry P. W., Beck-Sague C. M., Bland L. A., Aguero S. M., Arduino M. J., Minuth A. N., Murray R. A., Swenson J. M., Jarvis W. R. Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J Infect Dis. 1990 Jan;161(1):85–90. doi: 10.1093/infdis/161.1.85. [DOI] [PubMed] [Google Scholar]
  7. Safranek T. J., Jarvis W. R., Carson L. A., Cusick L. B., Bland L. A., Swenson J. M., Silcox V. A. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 1987 Jul 23;317(4):197–201. doi: 10.1056/NEJM198707233170403. [DOI] [PubMed] [Google Scholar]
  8. Smithwick R. W., Bigbie M. R., Jr, Ferguson R. B., Karlix M. A., Wallis C. K. Phenolic acridine orange fluorescent stain for mycobacteria. J Clin Microbiol. 1995 Oct;33(10):2763–2764. doi: 10.1128/jcm.33.10.2763-2764.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Steingrube V. A., Wallace R. J., Jr, Steele L. C., Pang Y. J. Mercuric reductase activity and evidence of broad-spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria. Antimicrob Agents Chemother. 1991 May;35(5):819–823. doi: 10.1128/aac.35.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Swenson J. M., Wallace R. J., Jr, Silcox V. A., Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985 Dec;28(6):807–811. doi: 10.1128/aac.28.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tebas P., Sultan F., Wallace R. J., Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis. 1995 Feb;20(2):443–444. doi: 10.1093/clinids/20.2.443. [DOI] [PubMed] [Google Scholar]
  12. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995 Sep;33(9):2233–2239. doi: 10.1128/jcm.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Villaire M. Centers provide OAM with 'deliverables'. Altern Ther Health Med. 1997 Jan;3(1):20–24. [PubMed] [Google Scholar]
  14. Wallace R. J., Jr, Meier A., Brown B. A., Zhang Y., Sander P., Onyi G. O., Böttger E. C. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother. 1996 Jul;40(7):1676–1681. doi: 10.1128/aac.40.7.1676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wallace R. J., Jr, Tanner D., Brennan P. J., Brown B. A. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med. 1993 Sep 15;119(6):482–486. doi: 10.7326/0003-4819-119-6-199309150-00006. [DOI] [PubMed] [Google Scholar]
  16. Yakrus M. A., Reeves M. W., Hunter S. B. Characterization of isolates of Mycobacterium avium serotypes 4 and 8 from patients with AIDS by multilocus enzyme electrophoresis. J Clin Microbiol. 1992 Jun;30(6):1474–1478. doi: 10.1128/jcm.30.6.1474-1478.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES